|1.||Nicolau, David P: 5 articles (09/2015 - 02/2012)|
|2.||Sharma, Namrata: 4 articles (01/2016 - 03/2010)|
|3.||Roberts, Jason A: 4 articles (05/2015 - 01/2011)|
|4.||Udy, Andrew A: 4 articles (05/2015 - 01/2011)|
|5.||Lipman, Jeffrey: 4 articles (05/2015 - 01/2011)|
|6.||Roberts, Michael S: 4 articles (05/2015 - 01/2011)|
|7.||Chen, Yao-Shen: 4 articles (02/2010 - 09/2002)|
|8.||Satpathy, Gita: 3 articles (01/2016 - 03/2010)|
|9.||Agarwal, Tushar: 3 articles (01/2016 - 03/2010)|
|10.||Shenoy, Erica S: 3 articles (09/2015 - 06/2014)|
11/01/2007 - "Cefazolin, administered in the high dose used at our institution, is effective for prevention against infection with the most prevalent pathogens during and immediately after cardiac surgery. "
03/01/1978 - "One infection in a diabetic patient did not respond; despite high concentrations of cefazolin in serum, no detectable antibiotic was present in her infected metatarsal, and the infecting Escherichia coli (minimal inhibitory concentration, 16 micrograms/ml) was not eradicated during therapy. "
01/01/1987 - "Since the efficacy of the two protocols in preventing major infections was the same, the authors recommend the short prophylaxis with cephazolin for cardiac surgery patients."
12/01/2013 - "Cefazolin alone was less effective in preventing infection compared with the other antibiotic regimens (p = 0.03). "
03/15/1998 - "A rabbit model was used to test the efficacy of cefazolin administered in various therapeutic regimens in preventing iatrogenic Staphylococcus aureus infections during spinal instrumentation. "
|2.||Wound Infection (Wound Infections)
01/01/1992 - "Although cefazolin prophylaxis has proven efficacy in vascular surgery, Staphylococcus aureus wound infections are still an important postoperative complication. "
01/01/1991 - "In conclusion, a single preoperative dose of 1 g cefazolin proved to be effective for reducing the wound infection rate in non-cardiac thoracic surgery."
07/01/2011 - "We conducted a prospective, randomized, double-blind, placebo-controlled trial comparing wound infection rates in 404 patients (203 received prophylactic cefazolin, 201 received a placebo) undergoing TIVAD insertion. "
12/01/2000 - "Deep wound infections of the leg were more common in the cefazolin group. "
09/01/1998 - "Synergism between poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model."
09/01/2003 - "High proportions of MR-GPB PD peritonitis episodes, along with local factors, make empiric cefazolin unsuitable for many regional PD patients in Western Australia."
09/01/2003 - "Cefazolin use in methicillin-resistant staphylococcal peritonitis."
01/01/1999 - "The Ad Hoc Advisory Committee on Peritonitis Management has recommended intraperitoneal (i.p.) cefazolin and an aminoglycoside as empiric therapy for the treatment of peritonitis. "
01/01/1999 - "We analyzed peritonitis data from January 1, 1996 to June 30, 1997, prior to switching over to cefazolin. "
01/01/1985 - "Peritonitis was usually treated with intraperitoneal administration of cefazolin sodium, and 61% of the episodes were treated at home. "
04/01/1973 - "Cefazolin treatment appeared effective in 82 of 85 patients, including four with endocarditis. "
02/07/1977 - "Other studies report unsuccessful therapy of staphylococcal endocarditis with cefazolin."
02/01/2015 - "Cefazolin can likely be used for the treatment of MSSA bacteraemia (except endocarditis), without consideration of an InE."
06/13/1977 - "Cefazolin and Staphylococcus aureus endocarditis."
02/07/1977 - "Two patients with staphylococcal endocarditis were treated unsuccessfully with cefazolin sodium. "
|5.||Urinary Tract Infections (Urinary Tract Infection)
05/01/2010 - "Different antibacterial therapies are initiated clinically due to treatment protocol differences among institutions, disease severity, etc. We studied the efficacy of cefazolin (CEZ), a first-generation cephalosporin, as first-line parenteral treatment in acute upper urinary tract infection. "
12/01/1970 - "[Clinical studies of Cefazolin in urinary tract infections]."
01/01/2014 - "However, using the 2014 cefazolin breakpoints for urinary tract infections, 81.2% of the urine isolates were susceptible. "
01/01/2011 - "The procedure of UV-spectroscopy of cefazolin in mixed saliva of patients with urinary tract infection was developed."
05/01/2010 - "[Cefazolin efficacy and antibiotic sensitivity against pathogenic bacteria in pediatric with acute upper urinary tract infection]."
|10.||Anti-Bacterial Agents (Antibiotics)
|4.||Continuous Ambulatory Peritoneal Dialysis (CAPD)